Free Trial

Fortress Biotech (FBIOP) SEC Filings & 10K Form

Fortress Biotech logo
$8.19 +0.30 (+3.80%)
As of 07/7/2025 03:42 PM Eastern

Recent Fortress Biotech SEC Filings

DateFilerForm TypeView
06/23/2025
7:55 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
5:46 PM
Checkpoint Therapeutics, Inc. (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech (Filed by)
Form SCHEDULE 13D/A
06/03/2025
5:34 PM
Checkpoint Therapeutics, Inc. (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form DEFA14A
04/02/2025
11:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form EFFECT
04/02/2025
11:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form EFFECT
04/02/2025
11:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form EFFECT
04/02/2025
11:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form EFFECT
04/01/2025
5:39 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form POS AM
04/01/2025
5:39 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form POS AM
04/01/2025
5:42 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form POS AM
04/01/2025
5:42 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form POS AM
03/10/2025
7:30 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
7:30 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
3:25 PM
Checkpoint Therapeutics, Inc. (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
3:20 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:05 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2025
5:26 PM
Checkpoint Therapeutics, Inc. (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech (Filed by)
Form SCHEDULE 13D/A
01/03/2025
5:26 PM
Fortress Biotech, Inc. (Filed by)
Fortress Biotech (Filed by)
MUSTANG BIO, INC. (Subject)
Form SCHEDULE 13D/A
01/03/2025
4:50 PM
AVENUE THERAPEUTICS, INC. (Subject)
Fortress Biotech, Inc. (Filed by)
Fortress Biotech (Filed by)
Form SCHEDULE 13D/A
01/03/2025
3:20 PM
Fortress Biotech, Inc. (Reporting)
Fortress Biotech (Reporting)
MUSTANG BIO, INC. (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/03/2025
3:21 PM
AVENUE THERAPEUTICS, INC. (Issuer)
Fortress Biotech, Inc. (Reporting)
Fortress Biotech (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/23/2024
3:30 PM
Fortress Biotech, Inc. (Issuer)
Fortress Biotech (Issuer)
Jin David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:50 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:24 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
8:11 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2024
3:05 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 424B3
10/25/2024
9:15 AM
Fortress Biotech, Inc. (Subject)
Fortress Biotech (Subject)
HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G
10/07/2024
11:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form EFFECT
09/27/2024
3:53 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/25/2024
3:45 PM
Fortress Biotech, Inc. (Issuer)
Fortress Biotech (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2024
3:45 PM
Fortress Biotech, Inc. (Subject)
Fortress Biotech (Subject)
ROSENWALD LINDSAY A MD (Filed by)
Form SC 13D/A
09/23/2024
7:00 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 424B5
09/20/2024
8:28 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 424B5
08/13/2024
3:15 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2024
4:04 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 424B5
07/25/2024
4:26 PM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
7:00 AM
Fortress Biotech, Inc. (Filer)
Fortress Biotech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
7:42 AM
Fortress Biotech, Inc. (Issuer)
Fortress Biotech (Issuer)
Jin David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
7:00 AM
Fortress Biotech, Inc. (Issuer)
Fortress Biotech (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
7:30 AM
Fortress Biotech, Inc. (Issuer)
Fortress Biotech (Issuer)
ROSENWALD LINDSAY A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad)

Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.

We recently interviewed Rickards to get the full story and understand how everyday Americans can pre
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FBIOP) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners